ABT-670

CC1=CC(=CC=C1)C(=O)NCN2CCC(CC2)C3=[N+]([O-])C=CC=C3

InChIKey=PUMMPCXNEPHBNN-UHFFFAOYSA-N

InChI=1S/C19H23N3O2/c1-15-5-4-6-17(13-15)19(23)20-14-21-11-8-16(9-12-21)18-7-2-3-10-22(18)24/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,20,23)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.	2006-12-14	17149874

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:38:44 GMT 2025` Edited by `admin` on `Mon Mar 31 21:38:44 GMT 2025`
Record UNII	4L6071XH2J
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

ABT-670

Common Name

English

3-METHYL-N-(1-OXY-3',4',5',6'-TETRAHYDRO-2'H-(2,4'-BIPYRIDINE)-1'-YLMETHYL)BENZAMIDE

Preferred Name

English

BENZAMIDE, 3-METHYL-N-((4-(1-OXIDO-2-PYRIDINYL)-1-PIPERIDINYL)METHYL)-

Systematic Name

English

Code System Code Type Description

WIKIPEDIA

ABT-670